Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- development of hepatocellular carcinoma
研究概览
简要总结
Although serum alpha-fetoprotein level and abdominal sonography are the main methods to screening hepatocellular carcinoma (HCC) in cirrhotic patients, the adequate time and methods used are not completely well-defined. This study aims to assess the better timing and methods for prospectively screening HCC in patients with cirrhosis
详细描述
Well-diagnosed consecutive patients with cirrhosis were enrolled through a designed questionnaire to obtain basic information about gender, age, etiology of cirrhosis, conventional liver function tests, serum AFP level, education level, substance use including smoking, alcohol drinking, betel quid chewing, history of familial HCC, etc. Then the patients was followed by periodic abdominal sonography examination and determination of AFP and liver function. If AFP elevated or liver nodule appears, effort to diagnose HCC will be performed.If HCC was performed, the survival will be followed-up. As anti-viral therapy was found to decrease risk for HCC, patients with those therapy will be excluded.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Image diagnosis or biochemical diagnosis or presence of portal hypertension
排除标准
- •Presence of hepatocellular carcinoma
结局指标
主要结局
development of hepatocellular carcinoma
时间窗: during observation
nodule (with or without seum AFP greater than 400 ng/ml) confirmed by biopsy
次要结局
未报告次要终点
研究者
Jung-Fa,Tsai
Professor of Medicine
Kaohsiung Medical University Chung-Ho Memorial Hospital
